CD4 and immunodeficiency disease: Before the era of antiretrovial therapy (ART), historical TD vaccination studies in HIV patients showed complete lack of, or extremely impaired antibody responses in patients with severe immunodeficiency (CD4+ T-cells <300/μL)[30–32], while protective levels of antibody responses were observed in long-term non-progressors[28, 33].